These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 12526956)
1. Methotrexate therapy for primary biliary cirrhosis. Bach N; Bodian C; Bodenheimer H; Croen E; Berk PD; Thung SN; Lindor KD; Therneau T; Schaffner F Am J Gastroenterol; 2003 Jan; 98(1):187-93. PubMed ID: 12526956 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Babatin MA; Sanai FM; Swain MG Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885 [TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. Kaplan MM; Cheng S; Price LL; Bonis PA Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894 [TBL] [Abstract][Full Text] [Related]
4. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Kaplan MM Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200 [TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]
6. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis. Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496 [TBL] [Abstract][Full Text] [Related]
7. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. ter Borg PC; Schalm SW; Hansen BE; van Buuren HR; Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401 [TBL] [Abstract][Full Text] [Related]
14. The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Bach N; Thung SN; Schaffner F Arch Pathol Lab Med; 1998 Apr; 122(4):342-5. PubMed ID: 9648903 [TBL] [Abstract][Full Text] [Related]
15. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis. Jorgensen R; Angulo P; Dickson ER; Lindor KD Am J Gastroenterol; 2002 Oct; 97(10):2647-50. PubMed ID: 12385454 [TBL] [Abstract][Full Text] [Related]
16. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374 [TBL] [Abstract][Full Text] [Related]
17. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Kilmurry MR; Heathcote EJ; Cauch-Dudek K; O'Rourke K; Bailey RJ; Blendis LM; Ghent CN; Minuk GY; Pappas SC; Scully LJ; Steinbrecher UP; Sutherland LR; Williams CN; Worobetz LJ Hepatology; 1996 May; 23(5):1148-53. PubMed ID: 8621147 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. Lee YM; Kaplan MM Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960 [TBL] [Abstract][Full Text] [Related]
19. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. Poupon RE; Poupon R; Balkau B N Engl J Med; 1994 May; 330(19):1342-7. PubMed ID: 8152446 [TBL] [Abstract][Full Text] [Related]
20. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Corpechot C; Carrat F; Bonnand AM; Poupon RE; Poupon R Hepatology; 2000 Dec; 32(6):1196-9. PubMed ID: 11093724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]